Xtant Medical Holdings, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xtant Medical Holdings, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Xtant Medical Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was -37.1 %, a 613% decline year-over-year.
  • Xtant Medical Holdings, Inc. annual Return On Equity for 2023 was 1.56 %.
  • Xtant Medical Holdings, Inc. annual Return On Equity for 2022 was -27.3 %, a 84% decline from 2021.
  • Xtant Medical Holdings, Inc. annual Return On Equity for 2021 was -14.8 %, a 116% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -37.1 -44.3 -613% Jul 1, 2024 Sep 30, 2024
Q2 2024 -6.71 +20.3 +75.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -3.6 +22.5 +86.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 1.56 +28.9 Oct 1, 2023 Dec 31, 2023
Q3 2023 7.22 +35.5 Jul 1, 2023 Sep 30, 2023
Q2 2023 -27 -0.55 -2.08% Apr 1, 2023 Jun 30, 2023
Q1 2023 -26.1 -3.93 -17.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -27.3 -12.5 -84% Oct 1, 2022 Dec 31, 2022
Q3 2022 -28.3 -16.8 -147% Jul 1, 2022 Sep 30, 2022
Q2 2022 -26.5 -17.8 -204% Apr 1, 2022 Jun 30, 2022
Q1 2022 -22.2 +15 +40.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -14.8 -106 -116% Oct 1, 2021 Dec 31, 2021
Q3 2021 -11.4 -46.8 -132% Jul 1, 2021 Sep 30, 2021
Q2 2021 -8.72 -27.4 -147% Apr 1, 2021 Jun 30, 2021
Q1 2021 -37.2 -55.4 -305% Jan 1, 2021 Mar 31, 2021
Q4 2020 91.1 +71.4 +363% Oct 1, 2020 Dec 31, 2020
Q3 2020 35.4 -116 -76.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 18.7 -213 -91.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 18.1 -435 -96% Jan 1, 2020 Mar 31, 2020
Q4 2019 19.7 -5.7K -99.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 152 -692 -82% Jul 1, 2019 Sep 30, 2019
Q2 2019 232 -69 -22.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 453 +235 +108% Jan 1, 2019 Mar 31, 2019
Q4 2018 5.72K +5.55K +3262% Oct 1, 2018 Dec 31, 2018
Q3 2018 844 +684 +429% Jul 1, 2018 Sep 30, 2018
Q2 2018 301 +86.1 +40.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 218 -97.5 -30.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 170 -667 -79.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 160 +362 Jul 1, 2017 Sep 30, 2017
Q2 2017 215 +447 Apr 1, 2017 Jun 30, 2017
Q1 2017 315 -273 -46.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 838 +784 +1467% Oct 1, 2016 Dec 31, 2016
Q3 2016 -203 -410 -198% Jul 1, 2016 Sep 30, 2016
Q2 2016 -232 -365 -273% Apr 1, 2016 Jun 30, 2016
Q1 2016 589 +451 +328% Jan 1, 2016 Mar 31, 2016
Q4 2015 53.4 -104 -66% Oct 1, 2015 Dec 31, 2015
Q3 2015 207 +8.01 +4.02% Jul 1, 2015 Sep 30, 2015
Q2 2015 134 -173 -56.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 138 -660 -82.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 157 +3.3K Oct 1, 2014 Dec 31, 2014
Q3 2014 199 +753 Jul 1, 2014 Sep 30, 2014
Q2 2014 307 +551 Apr 1, 2014 Jun 30, 2014
Q1 2014 797 +927 Jan 1, 2014 Mar 31, 2014
Q4 2013 -3.14K -3.05K -3156% Oct 1, 2013 Dec 31, 2013
Q3 2013 -553 -467 -539% Jul 1, 2013 Sep 30, 2013
Q2 2013 -244 -150 -160% Apr 1, 2013 Jun 30, 2013
Q1 2013 -130 -18.5 -16.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -96.6 Oct 1, 2012 Dec 31, 2012
Q3 2012 -86.6 Jul 1, 2012 Sep 30, 2012
Q2 2012 -94.1 Mar 31, 2012 Jun 30, 2012
Q1 2012 -112 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.